Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis.
Rudolf BenzKathrin ZimmermannMarkus RechsteinerStefan BalabanovMarkus G ManzCorinne C WidmerPublished in: Leukemia & lymphoma (2020)